Bsense Bio Therapeutics
Ness Ziona
About Bsense Bio Therapeutics
Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $405.0K
- Funding stage: Seed
- Last round: Seed (Oct 2018)
- Website: bsense-bio.com
- Phone: 0548886348
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bsense-bio-therapeutics-145912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.